Who
Mark A. Ledoux
CEO/Chairman
Company insider
Files Form 4 as: CEO/Chairman, Natural Alternatives International.
In numbers
- Trades disclosed
- 153
- Buys
- 20
- Sells
- 22
- Bought
- $125K
- Sold
- $2.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Jan 2006
- Last trade
- 6 Mar 2026
- Last filed
- 10 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $9,5113,484 at $2.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code F | $9,5113,484 at $2.73 | filing |
| 6 Mar 2026filed 10 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 6 Mar 2026filed 6 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,490532 at $2.80 | filing |
| 6 Mar 2026filed 6 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,490532 at $2.80 | filing |
| 5 Mar 2026filed 6 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $600218 at $2.75 | filing |
| 5 Mar 2026filed 6 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $600218 at $2.75 | filing |
| 4 Mar 2026filed 6 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,385500 at $2.77 | filing |
| 4 Mar 2026filed 6 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,385500 at $2.77 | filing |
| 2 Mar 2026filed 3 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,395500 at $2.79 | filing |
| 2 Mar 2026filed 3 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,395500 at $2.79 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,425500 at $2.85 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,425500 at $2.85 | filing |
| 27 Feb 2026filed 27 Feb 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $700250 at $2.80 | filing |
| 27 Feb 2026filed 27 Feb 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $700250 at $2.80 | filing |
| 26 Feb 2026filed 27 Feb 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,423500 at $2.85 | filing |
| 26 Feb 2026filed 27 Feb 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,425500 at $2.85 | filing |
| 25 Feb 2026filed 27 Feb 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,405500 at $2.81 | filing |
| 25 Feb 2026filed 27 Feb 2026 | NAII Natural Alternatives InternationalPharmaceuticals | SEC FORM 4 Bought | $1,405500 at $2.81 | filing |
News
No headline names them, or the companies they trade most, lately.